Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/10/16 → 6/4/20 |
Funding
- United Therapeutics Corporation: $9,050.00
An Open-Label Extension Study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to Parenchymal Lung Disease
- Kolodziej, Andrew (PI)